SCHEMBL696494

SCHEMBL696494

C=CC(CCN)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751301 0.85 SLC6A3 (0.41)
SCHEMBL17011876 0.85 GSR (0.52)
SCHEMBL18833177 0.78
SCHEMBL9776472 0.78
SCHEMBL4452846 0.78 GPR84 (0.37)
SCHEMBL22844023 0.77 KMT2A (0.50)
SCHEMBL323329 0.76
SCHEMBL11813333 0.76
SCHEMBL3963535 0.76 SLC6A2 (0.56)
SCHEMBL11809830 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421523-A1 METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2012-02-29 EP disclosed
WO-2010121969-A1 METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-10-28 WO disclosed
CN-101848905-A Process for the enantioselective preparation of pregabalin ESTEVE LABOR DR 2010-09-29 CN disclosed